Improving Resilience And Equity In Breast Cancer Screening: Lessons From Covid-19 And Beyond | November 16-18, 2020 | Virtual Meeting
Meeting Information: November 16 - 18, 2020
This workshop was the fourth in the President’s Cancer Panel’s (the Panel) 2020–2021 series on cancer screening. The workshop brought together stakeholders from several sectors, including clinical care, healthcare systems, insurance companies, government agencies, research, and advocacy.
Agenda
Day 1: November 16, 2020
| Time | Agenda Item |
|---|---|
| 1:00 - 1:15 p.m. |
Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process, reflections from day 1 |
| 1:10 - 2:00 p.m. |
PCP Working Group Introduction and Presentation PCP introduction, introduce the working team and present work to date on the landscape of opportunities, barriers, and possible solutions |
| 2:15 - 3:15 p.m. |
Breast Cancer Screening Improvement Opportunities Session 1: Genetic Testing Expansion and Risk-Based Screening Opportunities to improve screening, associated barriers, and possible solutions
|
| 3:00 - 3:15 p.m. | Break |
| 3:15 - 4:15 p.m. |
Breast Cancer Screening Improvement Opportunities Session 2: Work to Eliminate Disparities in Screening Opportunities to improve screening, associated barriers, and possible solutions |
| 4:15 - 4:35 p.m. |
Working Group Review of Input and Final Comments Review of the day's stakeholder input and reactions to day's work |
| 4:35 - 5:00 p.m. | Response to Public Questions and Comments |
Day 2: November 18, 2020
| Time | Agenda Item |
|---|---|
| 1:00 - 1:15 p.m. |
Agenda Review and Administrative Statements Administrative remarks, facilitator introduces agenda and process, reflections from day 1 |
| 1:15 - 2:00 p.m. |
Breast Cancer Screening Improvement Opportunities Session 3: Alignment of Multiple Screening Guidelines Opportunities to improve screening, associated barriers, and possible solutions |
| 2:00 - 2:45 p.m. |
Breast Cancer Screening Improvement Opportunities Session 4: Perception Opportunities to improve screening, associated barriers, and possible solutions |
| 2:45 - 3:00 p.m. | Break |
| 3:00 - 4:30 p.m. |
Cross-Cutting Theme Review Review of the barriers falling into each cross-cutting theme, identification of any missing barriers
|
| 4:30 - 4:40 p.m. |
Panel Final Comments Brief review of input and panel discussion of next steps |
| 4:35 - 5:00 p.m. | Response to Public Questions and Comments |
Participants
| Name | Title & Affiliations |
|---|---|
| Elise Berman, MD |
Medical Director, Breast Imaging Fairfax Radiology Centers Fairfax, VA |
| Diana Buist, PhD, MPH |
Senior Investigator and Director of Research & Strategic Partnerships Kaiser Permanente Washington Seattle, WA |
| Ruth C. Carlos, MD, MS, FACR | Professor of Radiology Assistant Chair for Clinical Research University of Michigan Ann Arbor, MI |
| Andrew Crighton, MD |
Chief Executive Officer Roundtable on Cancer Morrisville, NC |
| Eva Cruz-Jove, MD |
Director Breast Imaging Senos Puerto Rico Dorado, PR |
| Paul DePriest, MD |
Executive Vice President and Chief Operating Officer Babtist Memorial Health Care Corporation Memphis, TN |
| Chyke Doubeni, MBBS, MPH |
Professor of Family Medicine Director, Center for Health Equity and Community Engagement Research Mayo Clinic Scottsdale, AZ |
| Mary Freivogel, MS, CGC |
Certified Genetic Counselor Invitae Highlands Ranch, CO |
| Rhonda Henry-Tillman, MD |
Vice Chair and Professor Department of Surgery Division Chief, Breast Surgical Oncology Director, Health Initiatives and Disparities Research University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute Little Rock, AR |
| Kevin Hughes, MD |
Surgical Oncologist Massachusetts General Hospital Boston, MA |
| Robert A. Ingram |
Member, President's Cancer Panel General Partner, Hatteras Venture Partners Durham, NC |
| Kim Johnson, MD |
Senior Director African American Health Equity Susan G. Komen Woodbridge, VA |
| Leah Johnson |
Product Manager Epic Verona, WI |
| Maureen R. Johnson, PhD |
Executive Secretary, President's Cancer Panel Special Assistant, Office of the Director National Cancer Institute National Institutes of Health Bethesda, MD |
| Janie Lee, MD |
Professor of Radiology Section Chief, Breast Imaging University of Washington School of Medicine Seattle, WA |
| Ana Maria Lopez, MD |
Professor and Vice Chair, Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia, PA |
| Barbara McAneny, MD |
Chief Executive Officer New Mexico Cancer Center Albuquerque, NM |
| Worta McCaskill-Stevens, MD |
Chief, Community Oncology and Prevention Trials Research Group Division of Cancer Prevention National Cancer Institute Rockville, MD |
| Diana Miglioretti, PhD |
Dean's Professor Division Chief, Biostatistics University of California, Davis Davis, CA |
| Jacqueline W. Miller, MD, FACS |
Captain, U.S. Public Health Service Medical Diector, National Breast and Cervical Cancer Early Detection Program Division of Cancer Prevention and Control Centers for Disease Control and Prevention Atlanta, GA |
| Edith P. Mitchell, MD, MACP, FCPP |
Member, President's Cancer Panel Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology Director, Center to Eliminate Health Disparities Associate Director of Diversity Affairs Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia, PA |
| Steven Narod, MD |
Senior Scientist Women's College Research Institute Women's College Hospital Toronto, ON |
| Shashanna Ndong, MD, FACMG, FAAP |
Medical Director Cigna Huntsville, AL |
| Lisa A. Newman, MD, MPH, FACS, FASCO |
Chief, Breast Surgery Section Director, Interdisciplinary Breast Disease Program Founding Medical Director, International Center for the Study of Breast Cancer Subtypes Weill Cornell Medicine-New York Presbyterian Hospital Network New York, NY |
| Olufunmilayo (Funmi) I. Olopade, MD, FACP |
Walter L. Palmer Distinguished Service Professor of Medicine Human Genetics Director Center for Clinical Cancer Genetics and Global Health The University of Chicago Medicine Chicago, IL |
| Rakesh Patel, MD |
Chair, High-Risk Breast Program Medical Director, Radiation Oncology Good Samaritan Hospital Los Gatos, CA |
| Etta Pisano, MD |
Professor in Residence, Radiology Harvard Medical School Cambridge, MA |
| Sandhya Pruthi, MD |
Professor of Medicine Mayo Clinic Rochester, MN |
| B. Scott Reiner |
Chief Executive Officer Adventist Health Roseville, CA |
| Lisa Richardson, MD |
Director Cancer Prevention and Control Centers for Disease Control and Prevention Atlanta, GA |
| Carolyn Runowicz, MD |
Executive Associate Dean Academic Affairs Florida International University Herbert Wertheim College of Medicine Miami, FL |
| Kimberly Sabelko, PhD |
Vice President, Scientific Strategy & Programs Susan G. Komen Dallas, TX |
| Judith Salerno, MD |
President New York Academy of Medicine New York, NY |
| Robert A. Smith, PhD |
Senior Vice President, Cancer Screening Department of Cancer Prevention and Early Detection Director, Center for Cancer Screening American Cancer Society Atlanta, GA |
| Patty Spears |
Scientific Research Manager and Patient Advocate University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hill, NC |
| Susan Stiles, RN, BSN, MHA, MBA, FACHE |
Executive, Oncology Product Management Cerner Corporation Kansas City, MO |
| Victor Vogel, MD, MHS, FASCO |
Director, Breast Medical Oncology/ Research Department of Hematology/Oncology Geisinger Health System Danville, PA |
| John P. Williams, MD, FACS |
Chair, President's Cancer Panel Medical Director, Breast Cancer School for Patients Gainesville, VA |
Summary
Participants discussed barriers and opportunities related to breast cancer screening, including those relevant to the healthcare system disruptions caused by the coronavirus disease (COVID-19) pandemic. The workshop was available to the public via live feed, and members of the public were invited to submit written comments and questions during and after the workshop. Participants were encouraged to live-Tweet at #ImprovingCancerScreening.
Meeting Outcomes
- Stakeholder input on opportunities, barriers, and possible solutions to improve breast cancer screening during and post COVID-19
- Stakeholder input on barriers included in cross-cutting theme areas